{"transactions":[{"id":1539665,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-17T16:15:27.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":971400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":971400,"derivative":{"exercise_price":0.76,"expiration_date":"2034-04-15","underlying":"Common Stock","underlying_shares":971400},"source":{"system":"sec-edgar","filing":"0001415889-24-010960","document":"form4-04172024_040403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000141588924010960/form4-04172024_040403.xml","form_type":"4"}},{"id":1831420,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-11T18:21:51.000Z","date":"2023-07-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8284,"value":4142.0,"ownership":{"direct":true},"balance_after":71952,"source":{"system":"sec-edgar","filing":"0001104659-23-080056","document":"tm2321093-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465923080056/tm2321093-1_4seq1.xml","form_type":"4"}},{"id":1831419,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-11T18:21:51.000Z","date":"2023-07-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.81,"value":4050.0,"ownership":{"direct":true},"balance_after":66952,"source":{"system":"sec-edgar","filing":"0001104659-23-080056","document":"tm2321093-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465923080056/tm2321093-1_4seq1.xml","form_type":"4"}},{"id":1832623,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-07T17:06:58.000Z","date":"2023-07-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.89,"value":4450.0,"ownership":{"direct":true},"balance_after":61952,"source":{"system":"sec-edgar","filing":"0001104659-23-079179","document":"tm2320881-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465923079179/tm2320881-1_4seq1.xml","form_type":"4"}},{"id":1835045,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T19:37:23.000Z","date":"2023-07-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8911,"value":4455.5,"ownership":{"direct":true},"balance_after":56952,"source":{"system":"sec-edgar","filing":"0001104659-23-078332","document":"tm2320620-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465923078332/tm2320620-1_4seq1.xml","form_type":"4"}},{"id":1917795,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T19:46:00.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":513600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":513600,"derivative":{"exercise_price":1,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":513600},"source":{"system":"sec-edgar","filing":"0001104659-23-046887","document":"tm2312963-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465923046887/tm2312963-4_4seq1.xml","form_type":"4"}},{"id":2216691,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T16:05:57.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":275250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":275250,"derivative":{"exercise_price":1.66,"expiration_date":"2032-04-19","underlying":"Common Stock","underlying_shares":275250},"source":{"system":"sec-edgar","filing":"0001104659-22-076811","document":"tm2220275-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465922076811/tm2220275-1_4seq1.xml","form_type":"4"}},{"id":2293415,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-20T16:24:58.000Z","date":"2022-04-19","kind":"grant","acquired":true,"shares":275250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":275250,"derivative":{"exercise_price":1.66,"expiration_date":"2032-04-19","underlying":"Common Stock","underlying_shares":275250},"source":{"system":"sec-edgar","filing":"0001104659-22-047844","document":"tm2213143-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465922047844/tm2213143-2_4seq1.xml","form_type":"4"}},{"id":2418718,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T20:44:52.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":39853,"price":3,"value":119559.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option is fully vested."}],"balance_after":39853,"derivative":{"exercise_price":1.5,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":39853},"source":{"system":"sec-edgar","filing":"0001104659-22-010534","document":"tm225144-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465922010534/tm225144-1_4seq1.xml","form_type":"4"}},{"id":2418717,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-01T20:44:52.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":47824,"price":3,"value":143472.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was awarded 47,824 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022."}],"balance_after":51952,"source":{"system":"sec-edgar","filing":"0001104659-22-010534","document":"tm225144-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465922010534/tm225144-1_4seq1.xml","form_type":"4"}},{"id":2742679,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T16:31:53.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":207600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on April 19, 2022, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":207600,"derivative":{"exercise_price":12,"expiration_date":"2031-04-19","underlying":"Common Stock","underlying_shares":207600},"source":{"system":"sec-edgar","filing":"0001104659-21-053187","document":"tm2113596-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465921053187/tm2113596-2_4seq1.xml","form_type":"4"}},{"id":3077459,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-22T16:01:37.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":4128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was awarded 4,128 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of HOOKIPA Pharma Inc.'s Common Stock. The restricted stock units vest shall vest in four equal installments on March 20, 2021, May 15, 2021, August 15, 2021 and November 15, 2021. The restricted stock units may be settled only by delivering shares of HOOKIPA Pharma Inc.'s Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":4128,"source":{"system":"sec-edgar","filing":"0001104659-20-085605","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465920085605/a4.xml","form_type":"4"}},{"id":3088153,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T20:15:14.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":40090,"price":0.3118,"value":12500.062,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":40090,"derivative":{"exercise_price":0.47,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":40090},"source":{"system":"sec-edgar","filing":"0001209191-20-041003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919120041003/doc4.xml","form_type":"4"}},{"id":3112890,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T20:22:57.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":14331,"derivative":{"exercise_price":0.63,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":14331},"source":{"system":"sec-edgar","filing":"0001209191-20-035923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919120035923/doc4.xml","form_type":"4"}},{"id":3169932,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-24T08:54:43.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest on February 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.03,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-20-050691","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465920050691/a4.xml","form_type":"4"}},{"id":3179526,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-08T21:40:18.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":56690,"price":0.2205,"value":12500.145,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":56690,"derivative":{"exercise_price":0.3495,"expiration_date":"2030-04-06","underlying":"Common Stock","underlying_shares":56690},"source":{"system":"sec-edgar","filing":"0001209191-20-023943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919120023943/doc4.xml","form_type":"4"}},{"id":3317580,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T21:45:17.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":29790,"price":0.4532,"value":13500.828,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":29790,"derivative":{"exercise_price":0.72,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":29790},"source":{"system":"sec-edgar","filing":"0001209191-20-001888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919120001888/doc4.xml","form_type":"4"}},{"id":3397930,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T20:37:47.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":15352,"price":0.8794,"value":13500.5488,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":15352,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":15352},"source":{"system":"sec-edgar","filing":"0001209191-19-052238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919119052238/doc4.xml","form_type":"4"}},{"id":3467272,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T20:04:46.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":7608,"price":1.7745,"value":13500.396,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":7608,"derivative":{"exercise_price":2.41,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":7608},"source":{"system":"sec-edgar","filing":"0001209191-19-041035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919119041035/doc4.xml","form_type":"4"}},{"id":3482150,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T20:13:05.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":14331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) June 18, 2020, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":14331,"derivative":{"exercise_price":2.7,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14331},"source":{"system":"sec-edgar","filing":"0001209191-19-038214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919119038214/doc4.xml","form_type":"4"}},{"id":3549839,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-24T17:33:04.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":604656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":604656,"derivative":{"exercise_price":14,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":604656},"source":{"system":"sec-edgar","filing":"0001104659-19-023450","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734412/000110465919023450/a4.xml","form_type":"4"}},{"id":3563642,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-03T20:17:32.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":4966,"price":2.7185,"value":13500.071,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4966,"derivative":{"exercise_price":4.4,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":4966},"source":{"system":"sec-edgar","filing":"0001209191-19-023093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919119023093/doc4.xml","form_type":"4"}},{"id":3703061,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:50:44.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":4999,"price":2.7,"value":13497.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4999,"derivative":{"exercise_price":4.47,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":4999},"source":{"system":"sec-edgar","filing":"0001209191-19-002037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919119002037/doc4.xml","form_type":"4"}},{"id":3797796,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:10:02.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":2171,"price":6.22,"value":13503.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":2171,"derivative":{"exercise_price":10.37,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":2171},"source":{"system":"sec-edgar","filing":"0001209191-18-053949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919118053949/doc4.xml","form_type":"4"}},{"id":3807047,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":91935,"kind":"person","name":"Aldag Jorn","position":1,"cik":"0001734412","reported_name":"Aldag Jorn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-26T22:37:05.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":1547,"price":8.72,"value":13489.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1547,"derivative":{"exercise_price":14.57,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":1547},"source":{"system":"sec-edgar","filing":"0001209191-18-052354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1622229/000120919118052354/doc4.xml","form_type":"4"}}]}